by angelliu | Jul 31, 2018 | News
Source: Reuters FRANKFURT (Reuters) – Bayer has agreed to sell its established prescription dermatology brands to Denmark’s Leo Pharma, as the German drugmaker focuses on integrating seed maker Monsanto and on bolstering its drug development pipeline. The...
by angelliu | Jul 24, 2018 | News
Source: Sienna Biopharmaceuticals Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today announced results from a Phase 1b maximal use (MUse) pharmacokinetic (PK) and safety study of SNA-120 (pegcantratinib),...
by QFR Solutions | Jul 12, 2018 | News
Source: FierceBiotech A new CSO isn’t all Dermavant got from GlaxoSmithKline: The Roivant unit has picked up the rights to the British drugmaker’s dermatology drug tapinarof in a deal worth up to £250 million ($330 million). The asset is poised to enter...
by angelliu | Jul 10, 2018 | News
Source: Cassiopea Lainate, Italy – 10 July 2018 – Cassiopea SpA (SIX: SKIN), a clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products, today announced that top line...
by QFR Solutions | Jun 28, 2018 | News
Source: Reuters Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world’s biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy benefit managers. The deal’s...
by angelliu | Jun 4, 2018 | News
Source: FierceBiotech Verrica Pharmaceuticals has filed to raise $86 million from public investors. The planned IPO will give Verrica the money it needs to take a treatment for viral skin infection molluscum through phase 3 and onto the market. West Chester,...
